BIOMAT Database Logo BIOMAT Database Logo

Single-Time-Point Dosimetry of 177Lu-PSMA-617 Radionuclide Therapy with SPECT/CT. 2023

Brian J Burkett

UI MeSH Term Description Entries
D008297 Male Males
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072098 Single Photon Emission Computed Tomography Computed Tomography An imaging technique using a device which combines TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON and TOMOGRAPHY, X-RAY COMPUTED in the same session. CT SPECT,CT SPECT Scan,SPECT CT,SPECT CT Scan,CT SPECT Scans,CT SPECTs,CT Scan, SPECT,CT Scans, SPECT,SPECT CT Scans,SPECT Scan, CT,SPECT Scans, CT,SPECT, CT,SPECTs, CT,Scan, CT SPECT,Scan, SPECT CT,Scans, CT SPECT,Scans, SPECT CT
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

Brian J Burkett
Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy.
May 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
[177Lu]PSMA-617 radionuclide therapy shows promise.
August 2018, Nature reviews. Urology,
Brian J Burkett
Radiation Dosimetry in 177Lu-PSMA-617 Therapy.
March 2022, Seminars in nuclear medicine,
Brian J Burkett
Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors.
July 2020, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy.
April 2024, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617.
August 2016, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients' Outcome.
September 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).
February 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Brian J Burkett
Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.
June 2019, Clinical nuclear medicine,
Brian J Burkett
[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer.
August 2018, The Lancet. Oncology,
Copied contents to your clipboard!